Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility
The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Apolipoproteins are the protein constituents of lipoproteins, the particles that transport cholesterol and triglycerides in the plasma. Numerous epidemiologic studies have associated variations in plasma levels of lipoproteins and apolipoproteins with the development of atherosclerosis. Furthermore, genetic variations in lipoproteins and apolipoproteins have been associated with disorders of lipid metabolism. Recent advances in biochemical and molecular genetic methods have resulted in an increased understanding of interindividual variations in lipoprotein metabolism and of their relationship to atherosclerosis and the dyslipoproteinemias. In particular, certain DNA restriction fragment length polymorphisms of the apolipoprotein genes have, in the last few years, been associated with atherosclerotic diseases and dyslipoproteinemias. We believe that genetic markers, when used in conjunction with traditional clinical and biochemical determinations, may one day be useful in predicting atherosclerosis susceptibility in the general population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and is a genetically validated target to reduce ASCVD risk.8–10,64–66”
From Clinical review on triglycerides (2020) · cites this paper as [65]
Citations
Cites
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
The Metabolic Basis of Inherited Disease.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-3-425_3 · Cited by 2,687
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
A protein cofactor of lecithin:Cholesterol acyltransferase
Fielding, C. J., Shore, V. G., & Fielding, P. E. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90776-0 · Cited by 724
Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34954-8 · Cited by 673
A specific apoprotein activator for lipoprotein lipase
LaRosa, J. C., Levy, R. I., Herbert, P., Lux, S. E., & Fredrickson, D. S. (1970) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(70)90468-7 · Cited by 668
Sniderman, A., Shapiro, S., Marpole, D., Skinner, B., Teng, B., & Kwiterovich, P. O. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.604 · Cited by 633
Complete protein sequence and identification of structural domains of human apolipoprotein B
Knott, T. J., Pease, R. J., Powell, L. M., Wallis, S. C., Rall, S. C., Innerarity, T. L., Blackhart, B., Taylor, W. H., Marcel, Y., Milne, R., et al. (1986) · Nature · doi:10.1038/323734a0 · Cited by 620
Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons.
Kane, J. P., Hardman, D. A., & Paulus, H. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2465 · Cited by 584
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Self-citationApolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537
Human plasma lipoprotein [a]. Structural properties.
Gaubatz, J. W., Heideman, C., Gotto, A. M., Morrisett, J. D., & Dahlen, G. H. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32663-2 · Cited by 453
Ehnholm, C., Lukka, M., Kuusi, T., Nikkilä, E., & Utermann, G. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38833-7 · Cited by 405
Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction
MURAI, A., MIYAHARA, T., FUJIMOTO, N., MATSUDA, M., & KAMEYAMA, M. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90048-1 · Cited by 383
Karathanasis, S. K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6374 · Cited by 358
(1981) · PubMed · Cited by 341
Self-citationFamilial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery Disease
Norum, R. A., Lakier, J. B., Goldstein, S., Angel, A., Goldberg, R. B., Block, W. D., Noffze, D. K., Dolphin, P. J., Edelglass, J., Bogorad, D. D., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206243062503 · Cited by 304
Apolipoprotein B–Gene DNA Polymorphisms Associated with Myocardial Infarction
Hegele, R. A., Huang, L.-S., Herbert, P. N., Blum, C. B., Buring, J. E., Hennekens, C. H., & Breslow, J. L. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612113152403 · Cited by 275
Self-citationDEANOL IN SPONTANEOUS AND INDUCED DYSKINESIAS
Laterre, E. C., & Fortemps, E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92592-1 · Cited by 253
DNA POLYMORPHISM ADJACENT TO HUMAN APOPROTEIN A-1 GENE: RELATION TO HYPERTRIGLYCERIDAEMIA
Rees, A., Stocks, J., Shoulders, C. C., Galton, D. J., & Baralle, F. E. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91440-x · Cited by 241
Apolipoprotein E phenotypes and hyperlipidemia
Utermann, G., Kindermann, I., Kaffarnik, H., & Steinmetz, A. (1984) · Human Genetics · doi:10.1007/bf00286508 · Cited by 239
Structure of the human apolipoprotein B gene.
Blackhart, B. D., Ludwig, E. M., Pierotti, V. R., Caiati, L., Onasch, M. A., Wallis, S. C., Powell, L., Pease, R., Knott, T. J., & Chu, M. L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66718-3 · Cited by 236
The complete cDNA and amino acid sequence of human apolipoprotein B-100.
Chen, S. H., Yang, C. Y., Chen, P. F., Setzer, D., Tanimura, M., Li, W. H., Gotto, A. M., & Chan, L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69248-8 · Cited by 228
Law, A., Powell, L. M., Brunt, H., Knott, T. J., Altman, D. G., Rajput, T., Wallis, S. C., Pease, R. J., Priestley, L. M., Scott, J., et al. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91222-5 · Cited by 216
SHEE, W., & COWAN, H. K. (1947) · The Lancet · doi:10.1016/s0140-6736(47)90110-4 · Cited by 213
Shee, W., & Hk, C. (1947) · PubMed · Cited by 212
Ordovas, J. M., Schaefer, E. J., Salem, D., Ward, R. H., Glueck, C. J., Vergani, C., Wilson, P. W. F., & Karathanasis, S. K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603133141102 · Cited by 202
Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2
Breslow, J. L., Zannis, V. I., SanGiacomo, T. R., Third, J. L., Tracy, T., & Glueck, C. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38060-3 · Cited by 174
Self-citationRees, A., Stocks, J., Sharpe, C. R., Vella, M. A., Shoulders, C. C., Katz, J., Jowett, N. I., Baralle, F. E., & Galton, D. J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112062 · Cited by 158
Fager, G., Wiklund, O., Olofsson, S. O., Wilhelmsen, L., & Bondjers, G. (1981) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.1.4.273 · Cited by 139
Ehnholm, C., Mahley, R. W., Chappell, D. A., Weisgraber, K. H., Ludwig, E., & Witztum, J. L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5566 · Cited by 135
Apolipoprotein E polymorphism and hyperlipidemia.
Assmann, G., Schmitz, G., Menzel, H. J., & Schulte, H. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.5.641 · Cited by 135
Kessling, A. M., Horsthemke, B., & Humphries, S. E. (1985) · Clinical Genetics · doi:10.1111/j.1399-0004.1985.tb00403.x · Cited by 130
Baggio, G., Manzato, E., Gabelli, C., Fellin, R., Martini, S., Enzi, G. B., Verlato, F., Baiocchi, M. R., Sprecher, D. L., & Kashyap, M. L. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112332 · Cited by 119
Eto, M., Watanabe, K., & Ishii, K. (1986) · Clinical Genetics · doi:10.1111/j.1399-0004.1986.tb00547.x · Cited by 112
Weisgraber, K. H., Rall, S. C., Innerarity, T. L., Mahley, R. W., Kuusi, T., & Ehnholm, C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111287 · Cited by 111
GENETIC POLYMORPHISMS OF APOLIPOPROTEIN C-III AND INSULIN IN SURVIVORS OF MYOCARDIAL INFARCTION
Ferns, G., Ritchie, C. D., Stocks, J., & Galton, D. J. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90350-2 · Cited by 111
Rall, S. C., Weisgraber, K. H., Mahley, R. W., Ogawa, Y., Fielding, C. J., Utermann, G., Haas, J., Steinmetz, A., Menzel, H. J., & Assmann, G. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90928-2 · Cited by 105
Lusis, A. J., Heinzmann, C., Sparkes, R. S., Scott, J., Knott, T. J., Geller, R., Sparkes, M. C., & Mohandas, T. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.3929 · Cited by 105
Rw, M., & Angelin, B. (1984) · PubMed · Cited by 94
Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia
Stalenhoef, A. F. H., Casparie, A. F., Demacker, P. N. M., Stouten, J. T. J., Lutterman, J. A., & Laar, A. V. (1981) · Metabolism · doi:10.1016/0026-0495(81)90072-x · Cited by 91
Yamamura, T., Yamamoto, A., Sumiyoshi, T., Hiramori, K., Nishioeda, Y., & Nambu, S. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111532 · Cited by 91
Genetic variation in human apolipoprotein E
Wardell, M. R., Suckling, P. A., & Janus, E. D. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38055-x · Cited by 89
Young, S. G., Bertics, S. J., Scott, T. M., Dubois, B. W., Curtiss, L. K., & Witztum, J. L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35734-4 · Cited by 87
Evolution of lipoproteins deduced from protein sequence data
Barker, W. C., & Dayhoff, M. O. (1977) · Comparative Biochemistry and Physiology Part B Comparative Biochemistry · doi:10.1016/0305-0491(77)90060-8 · Cited by 84
Berg, K., Powell, L. M., Wallis, S. C., Pease, R., Knott, T. J., & Scott, J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7367 · Cited by 82
A DNA insertion in the apolipoprotein A-I gene of patients with premature atherosclerosis
Karathanasis, S. K., Zannis, V. I., & Breslow, J. L. (1983) · Nature · doi:10.1038/305823a0 · Cited by 82
Self-citationAnalysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia.
Lackner, K. J., Monge, J. C., Gregg, R. E., Hoeg, J. M., Triche, T. J., Law, S. W., & Brewer, H. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112766 · Cited by 82
Bouma, M. E., Beucler, I., Aggerbeck, L. P., Infante, R., & Schmitz, J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112590 · Cited by 77
DNA polymorphisms in the apolipoprotein C-III and insulin genes and atherosclerosis
Rees, A., Stocks, J., Williams, L. G., Caplin, J. L., Jowett, N. I., Camm, A. J., & Galton, D. J. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90072-3 · Cited by 76
In vitro activation of the enzymic activity of hepatic lipase by apoA‐II
Jahn, C. E., Osborne, J. C., Schaefer, E. J., & Brewer, H. B. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)80405-x · Cited by 71
Franceschini, G., Sirtori, C. R., Bosisio, E., Gualandri, V., Orsini, G. B., Mogavero, A. M., & Capurso, A. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90063-2 · Cited by 71
SEILHAMER, J. J., PROTTER, A. A., FROSSARD, P., & LEVY-WILSON, B. (1984) · DNA · doi:10.1089/dna.1.1984.3.309 · Cited by 71
Isolation and characterization of cDNA clones corresponding to two different human apoC-III alleles.
Karathanasis, S. K., Zannis, V. I., & Breslow, J. L. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34359-5 · Cited by 71
Self-citationIsoelectric heterogeneity of the cofactor protein for lipoprotein lipase in human blood plasma
Havel, R. J., Kotite, L., & Kane, J. P. (1979) · Biochemical Medicine · doi:10.1016/0006-2944(79)90063-2 · Cited by 69
Menzel, H. J., Assmann, G., Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43261-3 · Cited by 67
Regional myocardial volume perfused by the coronary artery branch: estimation in vivo.
Koiwa, Y., Bahn, R. C., & Ritman, E. L. (1986) · Circulation · doi:10.1161/01.cir.74.1.157 · Cited by 65
Apolipoprotein B-100 deficiency. Intestinal steatosis despite apolipoprotein B-48 synthesis.
Herbert, P. N., Hyams, J. S., Bernier, D. N., Berman, M. M., Saritelli, A. L., Lynch, K. M., Nichols, A. V., & Forte, T. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111986 · Cited by 62
Rees, A., Stocks, J., Paul, H., Ohuchi, Y., & Galton, D. J. (1986) · Human Genetics · doi:10.1007/bf00283939 · Cited by 61
Huang, L. S., Miller, D. A., Bruns, G. A., & Breslow, J. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.3.644 · Cited by 60
Self-citationMa, Y. H., Schumaker, V. N., Butler, R., & Sparkes, R. S. (1987) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.7.3.301 · Cited by 59
RFLP for the human apollpoprotein B gene: I;BamHI
Priestley, L. M., Knott, T. J., Wallis, S. C., Powell, L., Pease, R. J., Simon, A., & Scott, J. E. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.18.6789 · Cited by 57
Chromosomal localization of the human apoprotein ci gene and of a polymorphic apoprotein AII gene
Knott, T. J., Eddy, R. L., Robertson, M. E., Priestley, L. M., Scott, J., & Shows, T. B. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80368-x · Cited by 53
Wallis, S. C., Donald, J. A., FORREST, L. A., Williamson, R., & Humphries, S. E. (1984) · Human Genetics · doi:10.1007/bf00292585 · Cited by 51
Haplotypes of the human apoprotein AI-CIII-AIV gene cluster in coronary atherosclerosis
Ferns, G., & Galton, D. J. (1986) · Human Genetics · doi:10.1007/bf00401237 · Cited by 48
Contribution to the Inheritance of the Ag Groups
Bütler, R., Brunner, E. C., & Morganti, G. (1974) · Vox Sanguinis · doi:10.1111/j.1423-0410.1974.tb02726.x · Cited by 42
A variant primary structure of apolipoprotein C-II in individuals of African descent.
Menzel, H. J., Kane, J. P., Malloy, M. J., & Havel, R. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112342 · Cited by 41
Moll, P. P., Sing, C. F., Williams, R. R., Mao, S. J., & Kottke, B. A. (1986) · PubMed · Cited by 37
Detection of apolipoprotein E variants by an oligonucleotide "melting" procedure.
Funke, H., Rust, S., & Assmann, G. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.7.1285 · Cited by 35
Apolipoprotein AIMarburg: Studies on two kindreds with a mutant of human apolipoprotein AI
Utermann, G., Steinmetz, A., PAETZOLD, R., Wilk, J., Feussner, G., Kaffarnik, H., Mueller-Eckhardt, C., Seidel, D., Vogelberg, K. H., & Zimmer, F. (1982) · Human Genetics · doi:10.1007/bf00276597 · Cited by 34
Ag(c): recognition by a monoclonal antibody.
Robinson, M. T., Schumaker, V. N., Bütler, R., Berg, K., & Curtiss, L. K. (1986) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.6.3.341 · Cited by 26
Hasstedt, S. J., Ash, K. O., Williams, R. R., & Reynolds, J. F. (1986) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320240108 · Cited by 26
Sidoli, A., Giudici, G. A., Soria, M. R., & Vergani, C. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90022-5 · Cited by 26
A major gene for primary hypoalphalipoproteinemia.
Borecki, I. B., Rao, D. C., Third, J. L. H. C., Laskarzewski, P. M., & Glueck, C. J. (1986) · PubMed · Cited by 25
A DNA polymorphism of the apoprotein AII gene in hypertriglyceridaemia
Ferns, G., Shelley, C. S., Stocks, J., Rees, A., Paul, H., Baralle, F. E., & Galton, D. J. (1986) · Human Genetics · doi:10.1007/bf00282553 · Cited by 25
Zannis, V. I., Ordovas, J. M., Cladaras, C., Cole, F. S., Forbes, G., & Schaefer, E. J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38808-7 · Cited by 21
PvuII polymorphic site upstream to the human ApoCIII gene
Oettgen, P., Antonarakis, S. E., & Karathanasis, S. K. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.13.5571 · Cited by 17
Apolipoprotein B subspecies in chylomicrons isolated from a patient with chyluria
Lock, D. R., Hockenbery, D. M., Cunningham, J., Hahm, K. S., Kantor, O. S., & Schonfeld, G. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91218-4 · Cited by 13
Pvu II RFLP in the 5' of the human apolipoprotein B gene
Frossard, P. M., Gonzalez, P. A., Protter, A. A., COLEMAN, R. T., Funke, H., & Assmann, G. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.10.4373 · Cited by 10
Deletion polymorphism 5′ to the human apolipoprotein AI (apo AI) gene
Frossaid, P. M., COLEMAN, R. T., Protter, A. A., Seilhamer, J. J., Funke, H., & Assmann, G. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.21.8694 · Cited by 7
Research works printed but not linked: 21
- Anderson RA, 1986, Apolipoprotein A‐I gene locus haplotypes and HDL‐cholesterol levels, Clin Res, 34, 889A
- Anderson RA, 1985, Apoprotein A‐I linked genetic polymorphisms associated with high density lipoprotein levels, Clin Res, 33, 15
- Antonarakis SE, 1986, DNA polymorphism of the human apolipoprotein AI‐CIII‐AIV gene cluster, Am J Hum Genet (Suppl)., 39, 549
- Assmann G, 1986, Lack of association between RFLPs of the human apolipoprotein CII gene locus and clinical manifestations of atherosclerosis, Am J Hum Genet (Suppl)., 39, 260
- Avogaro P, 1978, Plasma levels of apolipoprotein AI and apoprotein B in human atherosclerosis, Artery., 4, 385
- Chen CH, 1983, Enhancement of Apolipoprotein Ai‐Activated Human Plasma Lecithin: Cholesterol Acyl Transferase Activity by Apoprotein Aii, Arteriosclerosis., 3, 489a
- Cole SA, 1986, A population genetics study of apolipoprotein AI gene polymorphism, Am J Hum Genet (Suppl)., 39, 691
- DHHS, 1980, Lipid Research Clinics Population Studies Data Book. The Prevalence Study, 28
- Fojo SS, 1986, Analysis of apo C‐II patients with apo C‐II deficiency, Circulation, 74, 284
- FrossardP ColemanR FunkeH AssmannG(1985):Molecular genetics of the human apolipoprotein AI‐CIII gene complex: Application to detection of susceptibility to atherosclerosis. In “Proceedings of the 4th International Atherosclerosis Symposium.” Munster GDR.
- Frossard PM, 1986, Genetic markers for coronary atherosclerosis in the human apolipoprotein AI‐CIII‐AIV gene complex, Am J Hum Genet (Suppl)., 39, 589
- Havekes L, 1986, The apolipoprotein E polymorphism at the DNA level, Circulation, 74, 322
- Karathanasis SK, 1986, DNA inversion inactivates both the apo AI and apo CIII genes in patients with combined apo AI‐apo CIII deficiency and premature coronary artery disease, Circulation, 74, 157
- Karathanasis SK, 1984, Apo CIII gene defect in patients with combined apo A‐I‐CIII deficiency and premature atherosclerosis, Arteriosclerosis, 4, 562a
- Kostner GM, 1986, The interactional of lipoproteina with glycosaminoglycans: Possible mechanism for its atherogenicity, Circulation, 74, 25
- Lim D, 1986, Deletion of an Alu sequence in the 5′ of the apolipoprotein AI gene associated with decreased serum HDL‐cholesterol levels, Am J Hum Genet (Suppl)., 39, 621
- Menzel HJ, 1984, Human apolipoprotein A‐I gene polymorphism, J Biol Chem, 259, 3070
- Schaefer EJ, 1986, Apolipoprotein E isoforms in the Framingham Offspring Study: Significance of variant alleles, Circulation, 74, 202
- Schulte H, 1986, The MspI RFLP 3′ to the human apolipoprotein AII gene is neutral with respect to atherosclerosis in Germans, Am J Hum Genet (Suppl)., 39, 293
- Scott J, 1985, High density lipoprotein composition is altered by a common DNA polymorphism adjacent to apolipoprotein A‐II gene in man, Lancet, 1, 770
- Weisgraber KH, 1986, Apolipoprotein B heparin binding sites: Insights into the receptor binding domain, Circulation, 74, 106
Cited by
Clinical review on triglycerides
Laufs, U., Parhofer, K. G., Ginsberg, H. N., & Hegele, R. A. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz785 · Cited by 544
Self-citationBoerwinkle, E., Xiong, W. J., Fourest, E., & Chan, L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.212 · Cited by 467
Genetics of hypertriglyceridemia
Dron, J. S., & Hegele, R. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00455 · Cited by 244
Self-citationGenetic factors affecting blood lipoproteins: the candidate gene approach.
Lusis, A. J. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38516-3 · Cited by 221
Leung, S. Y., Ng, T. H., Yuen, S. T., Lauder, I. J., & Ho, F. C. (1993) · Stroke · doi:10.1161/01.str.24.6.779 · Cited by 205
Metadata
- Authors
- Hegele, R. A., Breslow, J. L., & Cloninger, C. R.
- Affiliations
- Rockefeller University (US)
- Corresponding author
- Breslow, Jan L.
- Venue
- Genetic Epidemiology
- Publisher
- Wiley
- Published
- 1987-01
- Volume
- 4
- Issue
- 3
- Pages
- 163-184
- ISSN
- 0741-0395 (ISSN-L)
- 1098-2272
- OpenAlex
- W1729623267
- Cited by
- 60
- References
- 79
- Citations by year
- 2023: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2017: 1 · 2013: 2 · 2012: 1
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Genetic Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- apolipoproteins, atherosclerosis susceptibility, genetic variation, restriction fragment length polymorphism, apolipoprotein genes, dyslipoproteinemia, lipid metabolism disorders, genetic markers, lipoprotein metabolism, cardiovascular risk prediction
- MeSH terms
- Apolipoproteins, Arteriosclerosis, Chromosome Mapping, Disease Susceptibility, Genes, Humans, Polymorphism, Restriction Fragment Length, Genetic Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.